NCT02682667: Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Multiple Myeloma, Lymphoma, Non-Hodgkin, Leukemia-Lymphoma, Adult T-Cell, Hodgkin Disease, Non-Small Cell Lung Cancer